Abstract:The aim of the study was to investigate the risk factors of preprocedural laboratory investigations and drug effects to the incidence of contrast-induced nephropathy (CIN) in patients with diabetes who underwent coronary angiography or percutaneous coronary intervention and to assess the short-term safety. We retrospectively studied a total of 568 patients with diabetes who underwent coronary angiography or percutaneous coronary intervention from January, 2013 to January, 2014 in our hospital and compared the baseline clinical characteristics, especially the laboratory investigations and preprocedural drugs of those 2 groups (with CIN group and without CIN group), and half year follow-up. Overall, 53 (9.33%) patients were developed into CIN according to the definition of an increase of 25% from the baseline of serum creatinine concentration, supposing that on the basis of an increase of 44.2 μmol/L, the incidence would be 0.88% (5/568). No significant differences were found between the 2 groups with respect to age, diabetes mellitus duration, operation type, contrast type and volume, left ventricular ejection fraction, and combined diseases including hypertension, myocardial infarction, Arrhythmia, etc. However, patients with CIN tended to be lighter in body weight (P = 0.027) and were more often female [odds ratio (OR) = 2.8, P < 0.01], and also had a higher prevalence with acute coronary syndrome (OR = 5.1, P < 0.01). On the contrary to most studies, the preprocedural serum creatinine in with CIN group in our study was lower than without CIN group (P < 0.001). As for the preprocedural drugs, statins seemed could decrease the incidence of CIN (OR = 0.34, P < 0.05), and the use of diuretics might increase the occurrence of CIN (OR = 2.62, P < 0.05). As regard to the follow-up results, the hospitalization days and expense of with CIN group were significantly longer and higher than the without CIN group, but no significance was found between rehospitalization rate in half year. Preprocedural preventions are essential because there is no effective treatment for CIN our findings could be considered in clinical practice. There are many risk factors for CIN; it is necessary to distinguish the high-risk patients so as to carry out corresponding protection actions.

Effects of contrast media on renal functions of the patients undergoing coronary angiography

The Value of Cystatin C in renal Dysfunction Related to Percutaneous Coronary Intervention

Effect of the low-osmolality nonionic contrast media on renal function in patients undergoing coronary intervention: a prospective study

Comparison of Serum Cystatin C and Creatinine Level Changes for Prognosis of Patients After Peripheral Arterial Angiography.

The Effect of Different Drinking Methods to Preventing Renal Impairment after Coronary Angiography or Percutaneous Coronary Intervention

Correlation among PCI Contrast Agent Dose and Serum Creatinine, Estimated Glomerular Filtration Rate, Creatinine Clearance Rate and Adverse Events in Short and Middle Time Points

The association between nutritional risk and contrast-induced acute kidney injury in patients undergoing coronary angiography: a cross-sectional study

Contrast-induced Nephropathy in 532 Patients Undergoing Coronary Intervention

Clinical observation on hydration treatment to prevent contrast media-related renal injury for patients with different renal function levels

Microalbuminuria in patients with preserved renal function as a risk factor for contrast-Induced acute kidney injury following invasive coronary angiography.

Could serum cystatin C be employed in diagnosing contrast-induced nephropathy after nonemergency endovascular therapy with peripheral arterial diseases?

Protective effects of losartan in renal dysfunction during coronary angiography and intervention caused by low osmolar non-ionic contrast media

Drug Effects and Clinical Investigations for Contrast-Induced Nephropathy after Coronary Angiography or Percutaneous Coronary Intervention in Patients with Diabetes.

Erythrocyte Parameters, Anemia Conditions, and Sex Differences Are Associated with the Incidence of Contrast-Associated Acute Kidney Injury after Coronary Angiography.

Clinical Outcomes of Contrast-Induced Nephropathy in Patients Undergoing Percutaneous Coronary Intervention: A Prospective, Multicenter, Randomized Study to Analyze the Effect of Hydration and Acetylcysteine

Relations Between Markers of Renal Function, Coronary Risk Factors and the Occurrence and Severity of Coronary Artery Disease

Glomerular filtration decrease after diagnostic cardiac catheterisation in children with congenital cardiac malformation – the role of serum creatinine, cystatin C, neutrophil gelatinase and urine output monitoring

Recombinant Brain Natriuretic Peptide for the Prevention of Contrast-Induced Nephropathy in Patients with Chronic Kidney Disease Undergoing Nonemergent Percutaneous Coronary Intervention or Coronary Angiography: A Randomized Controlled Trial

Rosuvastatin Attenuated Contrast-Induced Nephropathy in Diabetes Patients with Renal Dysfunction.

Evaluation of contrast induced nephropathy related risk factors and long‐term results

Artificial Intelligence Algorithm-Based Computed Tomography Image in Assessment of Acute Renal Insufficiency of Patients Undergoing Percutaneous Coronary Intervention